Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis
In the pivotal clinical trials that led to FDA approvalincluding the SUSTAIN trials for diabetes management and the STEP trials for weight managementmusculoskeletal symptoms including joint pain were reported, but at rates generally comparable to placebo groups
Adding a nutritionist to the treatment gets more bang for the buck out of GLP-1 treatments, which can make them faster for hitting healthy target weights as well as achieving longer lasting results
The Office of Group Benefits provides insurance coverage to 212,000 people, including state employees, public school teachers, some local government workers, their family members as well as public sector retirees
It is safety. A History of Eating Disorders This section deserves nuance, not a blanket statement